ArticleJournal of clinical microbiology2015
Bacteremia caused by Arcobacter butzleri in an immunocompromised host.
Article in Journal of clinical microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
24 citing papers in PubMed, 61 citations in OpenAlex.
- Metagenomics enables parallel detection of 176 clinically relevant targets from faecal samples.Frontiers in cellular and infection microbiology · 2026Article
- The microbiological and clinical characteristics of 1,204 human cases of Aliarcobacter spp. infections that occurred in France between 2002 and 2024.Gut pathogens · 2025Article
- Determinants of Entero-Invasive and Non-Entero-Invasive Diarrheagenic Bacteria Among HIV-Positive and HIV-Negative Adults in Ghana.Medical sciences (Basel, Switzerland) · 2025Observational
- Pathogenicity of Arcobacter cryaerophilus in two human intestinal cell lines.Gut pathogens · 2025Article
- Occurrence, Sources and Virulence Potential ofEnvironmental science & technology · 2024Article
- Prolonged watery diarrhea and malnutrition caused byLe infezioni in medicina · 2024Article
- Virulence genotype and phenotype of two clinical isolates of Arcobacter butzleri obtained from patients with different pathologies.Archives of microbiology · 2023Article
- Widespread Multidrug Resistance ofAntibiotics (Basel, Switzerland) · 2023Article
- First case ofIDCases · 2023Article
- Genotyping, antibiotic resistance and prevalence of Arcobacter species in milk and dairy products.Veterinary medicine and science · 2022Article
- NRJ Media as the Gold-StandardFrontiers in microbiology · 2022Article
- Arcobacter Butzleri in an AIDS Patient.Case reports in infectious diseases · 2022Article
- Two-component regulatory systems inFrontiers in cellular and infection microbiology · 2022Review
- Article
- Occurrence and Antimicrobial Resistance ofAntibiotics (Basel, Switzerland) · 2021Article
- Antimicrobial Susceptibility and Genomic Analysis ofFrontiers in cellular and infection microbiology · 2021Article
- Mixed Aetiology of Diarrhoea in Infants Attending Clinics in the North-West Province of South Africa: Potential for Sub-Optimal Treatment.Pathogens (Basel, Switzerland) · 2020Article
- Arcobacter butzleri and intestinal colonization.Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia · 2020Article
- Article
- Prevalence and antimicrobial susceptibility ofGut pathogens · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Arcobacter butzleri is an emerging pathogen that has been implicated as the causative agent of persistent watery diarrhea. We describe a case involving a patient with chronic lymphocytic leukemia who developed invasive A. butzleri bacteremia. This case illustrates the unique challenges involved in diagnosing infections caused by emerging gastrointestinal pathogens.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.